Side Effects Common Side Effects Nausea: Feeling of sickness may occur, especially when starting treatment or after dose changes
However, it is prohibited method : intravenous injections and infusions in a total volume exceeding 100 ml within 12 hours (except hospitalization, procedures and clinical diagnosis) are classified as manipulation M2.2
Novartis: Bimagrumab/BYM338 Bimagrumab is an antibody against activin type II receptor (ActRII) meaning that it acts as an ActRII antagonist (It prevents ActRII from functioning)
Marissa's program is built around an actual medical relationship: full intake, baseline labs, a documented plan, dose titration based on your response, and the option to step down or pause if needed
For Respiratory Recovery Ideal for post-viral fatigue, asthma, bronchial inflammation, or sinus congestion
If you experience concerning period changes, discuss with your prescribing clinician whether adjusting the medication dose might be appropriate